STADA Arzneimittel AG
Stadastrasse 2-18
Bad Vilbel
61118
Germany
Tel: 496101-6030
Fax: 496101-603259
Website: http://www.stada.de/
33 articles about STADA Arzneimittel AG
-
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara
1/10/2024
Partners STADA and Alvotech announced that the European Commission issued a marketing authorization for Uzpruvo®, a biosimilar candidate to Stelara®.
-
NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America
12/11/2023
NEXGEL, Inc. announced a partnership with STADA Arzneimittel AG, a European leader in consumer health, to distribute and commercialize consumer health OTC products in North America in 2024.
-
STADA and Alvotech receive positive CHMP opinion for Europe’s first ustekinumab biosimilar to Stelara
11/10/2023
Partners STADA and Alvotech announced that the Committee for Medicinal Products for Human Use within the European Medicines Agency has adopted a positive opinion for Uzpruvo, a biosimilar candidate to Stelara®.
-
Amid strong performance in the first half of 2023, Stada Arzneimittel’s private equity owners are considering a potential sale, though there are still no definite plans, according to CEO Peter Goldschmidt.
-
Crescita Therapeutics and STADA Enter 15-Country Exclusive Licensing Agreement for Pliaglis®
8/18/2021
Crescita Therapeutics Inc. and STADA MENA DWC-LLC announced an exclusive commercialization and development license agreement for the exclusive rights to the topical anaesthetic cream Pliaglis®, in 15 countries in the Middle East and North Africa region, comprising: Saudi Arabia, the United Arab Emirates, Kuwait, Oman, Qatar, Bahrain, Jordan, Lebanon, Egypt, Algeria, Morocco, Tunisia, Iraq, Libya and Yemen.
-
Calliditas Therapeutics and STADA partner to register and commercialize specialty therapy for IgA Nephropathy in Europe
7/21/2021
Calliditas Therapeutics AB, and STADA Arzneimittel AG announced that they have entered into a license agreement to register and commercialize a novel specialty drug candidate for the treatment of the chronic autoimmune kidney disease Immunoglobulin A Nephropathy in the European Economic Area member states, Switzerland and the UK.
-
The brands Stada is picking up include venous treatment Venoruton, Coldrex for colds, Cetebe vitamin C supplements, Mebucaine for sore threats and Tavegyl for allergies, among others.
-
Alvotech and STADA Agree on Strategic Biosimilar Partnership
11/6/2019
Biopharmaceutical company Alvotech and global pharmaceutical company STADA Arzneimittel AG announced that they have entered into an exclusive strategic partnership for the commercialization of seven biosimilars in all key European markets and selected markets outside Europe.
-
Takeda Continues Strategic Divestitures With Sale of Select OTC and Non-Core Assets to STADA for $660 Million USD
11/5/2019
Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select products to STADA Arzneimittel AG, an international pharmaceutical company, for a total value of $660 million USD.
-
Today STADA announced the appointment of Peter Goldschmidt as new CEO and chairman of the board.
-
STADA Arzneimittel Names A New CEO, It's Fourth In The Last 15 Months
9/1/2017
-
Enzymatica AB: Continued Sales Growth And Breakthrough Order From STADA Arzneimittel
7/20/2017
-
STADA Arzneimittel CEO, CFO Quit After Takeover Failure
7/5/2017
-
Finally! STADA Arzneimittel Accepts $5.6 Billion Takeover Offer From Bain, Cinven
4/10/2017
-
While 3-Way Bids Go On, STADA Arzneimittel CEO's Car is Bugged, Received Photos of Himself in Personal or Private Biz Situations
3/29/2017
-
Fosun Pharma May Enter $4 Billion Bidding War For Germany's STADA Arzneimittel
3/10/2017
-
STADA Arzneimittel Hits a Record High After Receiving Two Takeover Proposals, Including a $3.7 Billion Bid From Cinven
2/13/2017
-
STADA Arzneimittel AG's Long-Serving CEO Retzlaff Resigns
8/15/2016
-
STADA Arzneimittel AG Grabs Sciotec Diagnostics for 17.2 Million Euros
8/26/2015
-
STADA Arzneimittel AG CEO Hunts For Deals Despite Political Tensions In Europe
6/5/2014